New surgical treatment strategies

European Neurology

Volumn 36, Issue 6, 1996, Pages 400-404

  Pollak, Pierre ^a   Benabid, Alint Louis ^a   Limousin, Patricia ^a   Krack, Paul ^a  

^a Cliniques et Biologiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN; BRAIN TRANSPLANTATION; ELECTROSTIMULATION THERAPY; GLOBUS PALLIDUS; HUMAN; METHODOLOGY; NEUROSURGERY; PARKINSON DISEASE; PHYSIOLOGY; REVIEW; THALAMUS NUCLEUS;

ANIMALS; BRAIN; BRAIN TISSUE TRANSPLANTATION; ELECTRIC STIMULATION THERAPY; GLOBUS PALLIDUS; HUMANS; NEUROSURGERY; PARKINSON DISEASE; THALAMIC NUCLEI;

EID: 0030338483     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Goetz CG, DcLong MR, Penn RD, Bakay AE: Neurosurgical horizons in Parkinson's disease, Neurology 1993:43:1-7.
2. Benabid AL, Poliak P, Hoffmann D, Le Bas JF, Gao DM: Chronic high-frequency thalamic stimulation in Parkinson's disease: in Roller WC, Paulson G (eds): Therapy of Parkinson’s Disease, ed 2, New York, Dekker, 1995, pp 381-402.
3. Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci 1990:13: 266-271.
4. DeLong MR: Primate models of movement disorders of basal ganglia origin, Trends Neurosci 1990:13:281-285.
5. Benabid AL, Poliak P, Louveau A, Henry S, De Rougement J: Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease, Appl Neurophvsiol 1987:50:344-346.
6. Agid Y, Javoy-Agid F, Ruberg M: Biochemistry of neurotransmilters in Parkinson's disease: in Marsden CD, Fahn S (eds): Movement Disorders 2, London, Butterworths, 1987, pp 166-230.
7. Tomac A, Lindqvist E, Lin L-FH, Ogrcn SO, Young D, Hoffer BJ, Olson L: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo, Nature 1995;373:335-339.
8. Beck KD, Valverde J, Alcxi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F: Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain, Nature 1995:373: 339-341.
9. Gage FH, Kawaja MD, Fisher IJ: Genetically modified cells: applications for intracerebral grafting, Trends Neurosci 1991; 14:328-333.
10. Jiao S, Gurevich V, Wolff JA: Long-term correction of rat model of Parkinson's disease by gene therapy, Nature 1993:362:450-453.
11. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet M, Perricaudet M, Mallet J: An adenovirus vector for gene transfer into neurons and glia in the brain, Science 1993:259:988-990.
12. During MJ, Naegele JR, O'malley KL, Geller AI: Long-term behavioral recovery in parkinsonian rats bv an HSV vector expressing tyrosine hydroxylase, Science 1994:266:1399-1403.
13. Kordower JH, Freeman TB, Snow BJ, Vingcrhoets FJC, Mufson EJ, San-berg PR, Hauser RA, Smith DA, Naucrt GM, Perl DP, Olanow CW: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease, N Engl J Med 1995:332:1118-1124.
14. Lindvall O, Widner H, Rchncrona S, Brundin P, Odin P, Gustavii B, Frackowiak R, Lcenders KL, Sawlc G, Rothwell JC, Björklund A, Marsden CD: Transplantation of fetal dopamine neurons in Parkinson's disease: One-vear clinical and neurophysiological observations in two patients with putaminal implants, Ann Neurol 1992:31:155-165.
15. Lindvall O: Neural transplantation in Parkinson’s disease: in Dunnett SB, Bjiirklund A (eds): Functional Neural Transplantation, Adv Neurosci, vol 2, New York, Raven Press, 1994, pp 103-137.
16. Widner H, Tetrad J, Rehncrona S, Snow B, Brundin P, Gustavii B, Bjork-lund A, Lindvall O, Langston JW: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by I-methyl-4-phenyl-l, 2, 3.6-tctrahvdropyridinc (MPTP), N Engl J Med 1992:327:1556-1563.
17. Poliak P, Benabid AL, Gcrvason C, Hoffmann D, Seigneurct E, Pcrrel J: Long-term cITccts of chronic stimulation of the ventral intermediate thalamic nucleus in different types of tremor, in Narabavashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds): Adv Neurol, vol 60, New York, Raven Press, 1993, pp 408-413.
18. Benabid AL, Poliak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, De Rougemont J: Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus, Lancet 1991:i: 403-406.
19. Limousin P, Poliak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret J, Benabid AL: Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation, Lancet 1995:345:91-95.
20. Benabid AL, Poliak P, Gao DM, Hoffmann D, Limousin P, Gay E, Payen I, Benazzouz A: Chronic electrical stimulation of the vcntralis intcrmcdius nucleus of the thalamus as a treatment of movement disorders, J Neurosurg 1996;84:203-214.
21. Matsumoto K, Asano T, Baba T, Miyamoto T, Ohmoto T: Long-term follow-up results of bilateral thalamotomv for parkinsonism, Appl Neurophysiol 1976;39:257-260.
22. Spellman JD: Parkinson’s Disease and Stereotaxic Neurosurgery, Amsterdam, Rodopi, 1991.
23. Kelly PJ, Gillingham FJ: The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease, A 10-year follow-up study, J Neurosurg 1980;53:332-337.
24. Kraycnbuehl H, Wvss OAM, Yasargil MG: Bilateral thalamotomy and pallidotomy as treatment for bilateral parkinsonism, J Neurosurg 1961:18: 429-444.
25. Siegfried J, Lippitz B, Bakay RAE, Kelly PJ: Bilateral chronic electrostimulation of ventroposterolatcral pallidum: A new therapeutic approach for alleviating all parkinsonian symptoms, Neurosurgery 1994:35:1126-1130.
26. Ohye C, Shibazaki T, Hirai T, Wada H, Hirato H, Kawashima Y: Further physiological observations on the ventralis intermedius neurons in the human thalamus, J Ncurophysiol 1989:61:488-500.
27. Wichmann T, Vitek JL, DeLong MR: Parkinson's disease and the basal ganglia: Lessons from the laboratory and from neurosurgery, Neuroscientist 1995:1:236-244.
28. Guiol G: Le traitement des syndromes parkinsoniens par la destruction du pallidum interne, Neurochirurgia 1958;1:94-98.
29. Hassler R, Riechen T, Mundinger F, Urn bach W, Gangleberger JA: Physiological observations in stereotaxic operations in extrapyramidal motor disturbances, Brain 1960:83:337-350.
30. Svennilson E, Torvik A, Lowe R, Leksell L: Treatment of parkinsonism by stereotactic thermolesions in the pallidal region, A clinical evaluation of 81 cases, Acta Psychiatr Neurol Scand 1960:35:358-377.
31. Lailinen LV, Bcrgcnhcim AT, Hariz MI: Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease, J Neurosurg 1992:76:53-61.
32. Dogali M, Fazzini F., Kolodny E, Eidelberg D, Stcrio D, Dcvinski O, Beric A: Stereotactic ventral pallidotomy for Parkinson’s disease, Neurology 1995:45:753-761.
33. Lozano AM, Lang AE, Galvcz-J menez, N, Miyasaki J, Duff J, Hutchinson WD, Dostrovsky JO: Effect of GPi pallidotomy on motor function in Parkinson's disease, Lancet 1995:346:1383-1387.
34. Sutton JP, Couldwcll W, Lew MF, Mallory L, Grafton S, DeGiorgio C, Welsh M, Apuzzo ML, Ahmadi J, Waters CH: Vcntroposterior medial pallidotomy in patients with advanced Parkinson's disease, Neurosurgery 1994:36:1112-1117.
35. Percheron G, Yelnik J, Francois C, Fenelon G, Talbi B: Analyse informationnelle du système lié aux ganglions de la base, Rev Ncurol 1994:150: 614-626.
36. Iacono RP, Shinta F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S: The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease, Neurosurgery 1995:36:1118-1124.
37. Bergman H, Wichmann T, Karnon B, DeLong MR: The primate subthalamic nucleus, II, Neuronal activity in the MPTP model of parkinsonism, J Neurophysiol 1994:72:507-520.
38. Bergman H, Wichmann T, DeLong MR: Reversal of experimental parkinsonism by lesion of the subthalamic nucleus, Science 1990:249:1436-1438.
39. Aziz TZ, Pcggs D, Argarwal E, Sambrook MA, Crossman AR: Subthalamic nucleotomy alleviates parkinsonism in the l-methyl-4-phenyl-l, 2, 3.6-tetrahydropyridine (MPTP(-exposed primates, Br J Neurosurg 1992:6: 575-582.
40. Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B: Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-lreatcd monkeys, Eur J Neurosci 1993:5:382-389.
41. Parent A, Hazrati LN: Functional anatomy of the basal ganglia, II, The place of subthalamic nucleus and external pallidum in basal ganglia circuitry, Brain Res Rev 1995;20:128-154.
42. Poliak P, Benabid AL, Limousin P, Benazzouz A, Hoffmann D, Le Bas JF, Perret JE: Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients: in Battistin L, Scarlato G, Caraccni T, Ruggieri S: Parkinson’s Disease, Adv Neurol, vol 69, Philadelphia, Lippincott-Raven, 1996, pp 591-594.
43. Limousin P, Poliak P, Benazzouz A, Hoffmann D, Broussolle E, Perret JE, Benabid AL: Bilateral subthalamic nucleus stimulation for severe Parkinson’s disease, Mov Disord 1995:10:672-674.